Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice

被引:222
作者
Eldar-Finkelman, H [1 ]
Schreyer, SA
Shinohara, MM
LeBoeuf, RC
Krebs, EG
机构
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Womens Hlth,Dept Med, Boston, MA 02115 USA
[2] Univ Washington, Dept Med, Seattle, WA USA
[3] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA
关键词
D O I
10.2337/diabetes.48.8.1662
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although the precise mechanisms contributing to insulin resistance and type 2 diabetes are unknown, it is believed that defects in downstream components of the insulin signaling pathway may be involved. In this work, we hypothesize that a serine/threonine kinase, glycogen synthase kinase-3 (GSK-3), may be pertinent in this regard. To test this hypothesis, we examined GSK-3 activity in two inbred mouse strains known to be susceptible (C57BL/6J) or resistant (A/J) to diet-induced obesity and diabetes. Examination of GSK-3 in fat, liver, and muscle tissues of C57BL/6J mice revealed that GSK-3 activity increased twofold in the epididymal fat tissue and remained unchanged in muscle and liver of mice fed a high-fat diet, compared with their low-fat diet-fed counterparts. In contrast, GSK-3 activity did not change in the epididymal fat tissue of A/J mice, regardless of the type of diet they were fed. In addition, both basal and diet-induced GSK-3 activity tvas higher (2.3- and 3.2-fold, respectively) in the adipose tissue of C57BL/6J mice compared with that in A/J mice, Taken together, our studies suggest an unsuspected Link between increased GSK-3 activity and development of insulin resistance and type 2 diabetes in fat tissue of C57BL/6J mice, and implicate GSK-3 as a potential factor contributing to susceptibility of C57BL/6J mice to diet-induced diabetes.
引用
收藏
页码:1662 / 1666
页数:5
相关论文
共 32 条
[11]  
CZECH MP, 1995, ANNU REV NUTR, V15, P441, DOI 10.1146/annurev.nu.15.070195.002301
[12]   Expression and characterization of glycogen synthase kinase-3 mutants and their effect on glycogen synthase activity in intact cells [J].
EldarFinkelman, H ;
Argast, GM ;
Foord, O ;
Fischer, EH ;
Krebs, EG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (19) :10228-10233
[13]   INACTIVATION OF GLYCOGEN-SYNTHASE KINASE-3 BY EPIDERMAL GROWTH-FACTOR IS MEDIATED BY MITOGEN-ACTIVATED PROTEIN KINASE/P90 RIBOSOMAL-PROTEIN S6 KINASE SIGNALING PATHWAY IN NIH/3T3 CELLS [J].
ELDARFINKELMAN, H ;
SEGER, R ;
VANDENHEEDE, JR ;
KREBS, EG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (03) :987-990
[14]   Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action [J].
EldarFinkelman, H ;
Krebs, EG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (18) :9660-9664
[15]  
FEA KD, 1998, BIOCHEMISTRY-US, V36, P12939
[16]   Control of glycogen synthesis in cultured human muscle cells [J].
Halse, R ;
Rochford, JJ ;
McCormack, JG ;
Vandenheede, JR ;
Hemmings, BA ;
Yeaman, SJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (02) :776-780
[17]   IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance [J].
Hotamisligil, GS ;
Peraldi, P ;
Budavari, A ;
Ellis, R ;
White, MF ;
Spiegelman, BM .
SCIENCE, 1996, 271 (5249) :665-668
[18]   Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects [J].
Krook, A ;
Roth, RA ;
Jiang, XJ ;
Zierath, JR ;
Wallberg-Henriksson, H .
DIABETES, 1998, 47 (08) :1281-1286
[19]   Insulin signal transduction and the IRS proteins [J].
Myers, MG ;
White, MF .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1996, 36 :615-658
[20]  
Myers MG, 1996, MOL CELL BIOL, V16, P4147